
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.095 | -5.17711171662 | 1.835 | 1.88 | 1.67 | 215190 | 1.77277573 | CS |
4 | -0.61 | -25.9574468085 | 2.35 | 2.86 | 1.67 | 1103936 | 2.33242065 | CS |
12 | -0.9075 | -34.2776203966 | 2.6475 | 9.79 | 1.53 | 7389150 | 5.50409051 | CS |
26 | -1.31 | -42.9508196721 | 3.05 | 9.79 | 1.53 | 3193748 | 5.47701966 | CS |
52 | -4.56 | -72.380952381 | 6.3 | 10.35 | 1.53 | 1711905 | 5.61425001 | CS |
156 | -90.06 | -98.1045751634 | 91.8 | 261.36 | 1.53 | 1093605 | 65.29672061 | CS |
260 | -342.78 | -99.4949494949 | 344.52 | 699.84 | 1.53 | 943077 | 130.19540557 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.